Valneva SE (VALN)
$5.56-6.24%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $527M
- Beta
- 1.35
- P/E (TTM)
- -2.81
- Short % float
- 0.23%
- Days to cover
- 9.6
- SI change
- +7.9%
- 1W
- -5.12%
- 1M
- -16.64%
- vs SPY 1W
- -4.98%
- vs SPY 1M
- -19.15%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on VALN?
- LOPJLB’s latest quantitative signal on Valneva SE (VALN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is VALN in?
- Valneva SE (VALN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Valneva SE (VALN) do?
- Valneva SE operates as a specialized biopharmaceutical company, concentrating its efforts on developing and bringing to market preventative vaccines for infectious diseases where current medical options are insufficient. Its portfolio of commercial travel vaccines includes IXIARO, an inactivated vaccine derived from Vero cell culture, which provides active immunity against Japanese encephalitis…